BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 38586465)

  • 21. Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy.
    Lee TH; Chen JJ; Wu CY; Yang CW; Yang HY
    Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34574015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.
    Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group
    Kidney Int; 2021 Oct; 100(4S):S1-S276. PubMed ID: 34556256
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia.
    Guedes M; Muenz DG; Zee J; Bieber B; Stengel B; Massy ZA; Mansencal N; Wong MMY; Charytan DM; Reichel H; Waechter S; Pisoni RL; Robinson BM; Pecoits-Filho R;
    J Am Soc Nephrol; 2021 Aug; 32(8):2020-2030. PubMed ID: 34244326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease.
    Kalantar-Zadeh K; Jafar TH; Nitsch D; Neuen BL; Perkovic V
    Lancet; 2021 Aug; 398(10302):786-802. PubMed ID: 34175022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible burden of hyperuricaemia on mortality in a community-based population: a large-scale cohort study.
    Otaki Y; Konta T; Ichikawa K; Fujimoto S; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Narita I; Kondo M; Shibagaki Y; Kasahara M; Asahi K; Watanabe T
    Sci Rep; 2021 Apr; 11(1):8999. PubMed ID: 33903733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kidney and hypertension in older adults.
    Bouarich H; Chávez Guillén A; Rodríguez Puyol D
    Med Clin (Barc); 2021 Aug; 157(4):178-184. PubMed ID: 33858674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents.
    Portolés J; Martín L; Broseta JJ; Cases A
    Front Med (Lausanne); 2021; 8():642296. PubMed ID: 33842503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperuricemia and chronic kidney disease: to treat or not to treat.
    Piani F; Sasai F; Bjornstad P; Borghi C; Yoshimura A; Sanchez-Lozada LG; Roncal-Jimenez C; Garcia GE; Hernando AA; Fuentes GC; Rodriguez-Iturbe B; Lanaspa MA; Johnson RJ
    J Bras Nefrol; 2021; 43(4):572-579. PubMed ID: 33704350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice.
    Gaubert M; Bardin T; Cohen-Solal A; Diévart F; Fauvel JP; Guieu R; Sadrin S; Maixent JM; Galinier M; Paganelli F
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 33561034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
    Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dirty little secret of urate-lowering therapy: useless to stop chronic kidney disease progression and may increase mortality.
    Gonzalez-Martin G; Cano J; Carriazo S; Kanbay M; Perez-Gomez MV; Fernandez-Prado R; Ortiz A
    Clin Kidney J; 2020 Dec; 13(6):936-947. PubMed ID: 33391737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection.
    Kielstein JT; Pontremoli R; Burnier M
    Curr Hypertens Rep; 2020 Oct; 22(12):102. PubMed ID: 33128170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin.
    Hanna RM; Streja E; Kalantar-Zadeh K
    Adv Ther; 2021 Jan; 38(1):52-75. PubMed ID: 33123967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between Serum Uric Acid and Mortality Risk in Hemodialysis Patients: A Multicenter Prospective Cohort Study.
    Yang Y; Qin X; Li Y; Yang S; Chen J; He Y; Huang Y; Lin Z; Li Y; Kong Y; Lu Y; Zhao Y; Wan Q; Wang Q; Huang S; Liu Y; Liu A; Liu F; Hou FF; Liang M
    Am J Nephrol; 2020; 51(10):823-832. PubMed ID: 33070128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between serum uric acid levels and mortality: a nationwide community-based cohort study.
    Konta T; Ichikawa K; Kawasaki R; Fujimoto S; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Narita I; Kondo M; Shibagaki Y; Kasahara M; Asahi K; Watanabe T
    Sci Rep; 2020 Apr; 10(1):6066. PubMed ID: 32269262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uric acid in CKD: has the jury come to the verdict?
    Bonino B; Leoncini G; Russo E; Pontremoli R; Viazzi F
    J Nephrol; 2020 Aug; 33(4):715-724. PubMed ID: 31933161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperuricemia and Hypertension: Links and Risks.
    Stewart DJ; Langlois V; Noone D
    Integr Blood Press Control; 2019; 12():43-62. PubMed ID: 31920373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation.
    Renaghan AD; Jaimes EA; Malyszko J; Perazella MA; Sprangers B; Rosner MH
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):289-297. PubMed ID: 31836598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex Differences in Kidney Replacement Therapy Initiation and Maintenance.
    Antlanger M; Noordzij M; van de Luijtgaarden M; Carrero JJ; Palsson R; Finne P; Hemmelder MH; Aresté-Fosalba N; Reisæter AV; Cases A; Traynor JP; Kramar R; Massy Z; Jager KJ; Hecking M;
    Clin J Am Soc Nephrol; 2019 Nov; 14(11):1616-1625. PubMed ID: 31649071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic Kidney Disease Diagnosis and Management: A Review.
    Chen TK; Knicely DH; Grams ME
    JAMA; 2019 Oct; 322(13):1294-1304. PubMed ID: 31573641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.